Healthy volunteers to test new diabetes Pill's body processing
NCT ID NCT07511010
First seen Apr 07, 2026 · Last updated Jun 17, 2026 · Updated 12 times
Summary
This early-stage study looks at how a high-fat meal changes the way a new diabetes pill (Chiglitazar/Metformin) is absorbed and processed in the body. It also checks how the drug builds up over multiple doses. The study involves 28 healthy Chinese adults aged 18-45 and does not aim to treat diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T2DM (TYPE 2 DIABETES MELLITUS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.